The clinical manifestations of systemic lupus erythematosus: a Cairo-Glasgow co-operative study.
The clinical features of 78 patients with SLE seen in Cairo and Glasgow are reviewed. Raynaud's phenomenon was recorded more frequently here than in previous series. The value of serial measurements of anti-DNA antibodies, C3 and C4 in the management of SLE is discussed. Although antibodies to native DNA paralleled the disease course in only a minority of SLE patients anti-DNA antibodies were present during all major SLE exacerbations and could be diagnostically useful. Serious systemic infections complicating the management of SLE patients could occur and their diagnosis is discussed.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D000367:Age Factors; D000974:Antibodies, Antinuclear / Q000032:analysis; D001168:Arthritis / Q000175:diagnosis; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis; D004534:Egypt; D005260:Female; D006801:Humans; D007677:Kidney Function Tests; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D010787:Photosensitivity Disorders / Q000175:diagnosis; D012606:Scotland
D000305:Adrenal Cortex Hormones; D000974:Antibodies, Antinuclear; D003176:Complement C3; D003181:Complement C4